A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2013
11/21/2013	WO2013054307A3 Antibodies and methods for wnt pathway-related diseases
11/21/2013	US20130310446 Mir-21 promoter driven targeted cancer therapy
11/21/2013	US20130310327 Histatin for Corneal Wound Healing and Ocular Surface Disease
11/21/2013	US20130310326 Histatin for Corneal Wound Healing and Ocular Surface Disease
11/21/2013	US20130310325 Administration of serine protease inhibitors to the stomach
11/21/2013	US20130310323 Methods of Treating Depression and Other Related Diseases
11/21/2013	US20130310322 Isolated extracellular matrix material including subserous fascia
11/21/2013	US20130310321 Diagnostic agent for ischemic heart disease risk group
11/21/2013	US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013	US20130310317 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
11/21/2013	US20130310316 Method and product for treatment and/or prevention of complications of prematurity
11/21/2013	US20130310314 Solid phase synthesis of h(gly2)glp-2
11/21/2013	US20130310313 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
11/21/2013	US20130310312 Combination of insulin with triazine derivatives and its use for treating diabetes
11/21/2013	US20130310309 Method for treating disorders of the skin
11/21/2013	US20130310308 Method of inhibiting clostridium difficile by administration of oritavancin
11/21/2013	US20130310307 Methods and compositions for treatment of multidrug-resistant bacterial and fungal infections
11/21/2013	US20130310305 Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
11/21/2013	US20130310271 Tuberculosis diagnostic test
11/21/2013	US20130309766 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
11/21/2013	US20130309720 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
11/21/2013	US20130309304 Compounds and methods
11/21/2013	US20130309294 New oral dissolving films for insulin administration, for treating diabetes
11/21/2013	US20130309291 Confection composition
11/21/2013	US20130309268 Compositions including transfer factor derived from eggs
11/21/2013	US20130309253 Cancer treatment with endothelin receptor antagonists
11/21/2013	US20130309249 Materials and methods for the prophylactic treatment of a pre-malignant condition
11/21/2013	US20130309247 Dimeric iap inhibitors
11/21/2013	US20130309232 Vascular endothelial growth factor 2
11/21/2013	US20130309231 Methods for using taci-immunoglobulin fusion proteins
11/21/2013	US20130309221 Human growth and differentiation factor gdf-5
11/21/2013	US20130309220 Compositions for treating microbial infections
11/21/2013	US20130309219 Treatment and Prevention of Bacterial Vaginosis and Gardnerella Vaginalis Infections
11/21/2013	US20130309215 Pharmaceutical composition
11/21/2013	US20130309211 Wnt1 for Treatment of Cardiovascular Disorders and Injuries
11/21/2013	US20130309208 Enhanced Medical Implant
11/21/2013	US20130309201 Oligonucleotide chelate complex - polypeptide compositions and methods
11/21/2013	US20130309198 Composition comprising at least to compounds which induces indolamine 2,3 - dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
11/21/2013	US20130309196 Antiviral compounds
11/21/2013	US20130309195 Antiviral compounds
11/21/2013	US20130309191 Compounds for the treatment of clostridium difficile-associated disease
11/21/2013	US20130309179 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with porphyromonas gingivalis
11/21/2013	US20130309173 Methods and compositions for maintenance of a functional wound
11/21/2013	DE102004043153B4 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin
11/20/2013	EP2664623A1 New antitumoral compounds
11/20/2013	EP2664622A2 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
11/20/2013	EP2664621A1 Antiviral agent
11/20/2013	EP2664614A1 Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups
11/20/2013	EP2664344A1 Ehrlichia canis diva (differentiate infection from vaccinated animals)
11/20/2013	EP2664343A2 Suppression of cancer
11/20/2013	EP2664342A2 Native (telopeptide) placental collagen compositions
11/20/2013	EP2664341A2 Native (telopeptide) placental collagen compositions
11/20/2013	EP2664340A2 A direct drug delivery system based on thermally responsive biopolymers
11/20/2013	EP2664339A2 YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
11/20/2013	EP2664338A1 Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level
11/20/2013	EP2664337A1 Amniotic membrane preparations and purified compositions and methods of use
11/20/2013	EP2663868A2 Methods and compositions for targeting sites of neovascular growth
11/20/2013	EP2663647A2 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
11/20/2013	EP2663637A1 Methods for accelerating the healing of connective tissue injuries and disorders
11/20/2013	EP2663578A2 Il-27 antagonists for treating inflammatory diseases
11/20/2013	EP2663576A2 Novel wnt compositions and therapeutic uses of such compositions
11/20/2013	EP2663367A1 Use of toll-like receptor agonist for treating cancer
11/20/2013	EP2663337A2 Method for delivering agents into cells using bacterial toxins
11/20/2013	EP2663335A1 A composition for the regeneration of atrophic tissues
11/20/2013	EP2663326A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
11/20/2013	EP2663325A1 Use of a vegf antagonist to treat angiogenic eye disorders
11/20/2013	EP2663324A1 Composition and method for treating cancer
11/20/2013	EP2663323A1 Methods targeting mir-128 for regulating cholesterol/lipid metabolism
11/20/2013	EP2663322A2 New uses of cyclophilin inhibitors
11/20/2013	EP2663321A2 Antigen surrogates in autoimmune disease
11/20/2013	EP2663320A1 Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
11/20/2013	EP2459207B1 Pharmaceutical composition for use in treating obesity, diabetes or to increase insulin sensitivity
11/20/2013	EP2371847B1 Peptides and their derived type APL of the HSP60 and pharmaceutical compositions
11/20/2013	EP2310031B1 Combination of a tiliroside and lysine-valine 5 diaminohydroxybutyrate
11/20/2013	EP2261328B1 Lipase variants for pharmaceutical use
11/20/2013	EP2142644B1 Mutated hyperthermophilic phosphotriesterases and uses thereof
11/20/2013	EP2120859B1 Sustained-release formulations comprising bmp-7 crystals
11/20/2013	EP2108655B1 Immune-modulating peptide
11/20/2013	EP2083841B1 SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1) PROTEIN FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES OF THE EYE
11/20/2013	EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use
11/20/2013	EP2041156B1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/20/2013	EP2040735B1 Isolated cationic fraction for treating a microbial infection
11/20/2013	EP1937293B1 Method of repairing meniscal tears
11/20/2013	EP1915171B1 Method of preserving the function of insulin-producing cells
11/20/2013	EP1694347B1 Glycopegylated erythropoietin
11/20/2013	EP1690545B1 Preparation of Product R and product so obtained
11/20/2013	EP1651762B1 Small interfering rna specific to sub-units alpha, alpha' and beta of the kinase protein ck2, and the applications of the same
11/20/2013	EP1567022B1 Sustained improver of muscular fatigue
11/20/2013	EP1565203B1 Templated native silk smectic gels
11/20/2013	CN203291214U Tobacco control active peptide polymerization liquid steam state cigarette
11/20/2013	CN103403153A Antimicrobial agents
11/20/2013	CN103403030A Methods for treating and diagnosing disease
11/20/2013	CN103403019A Engineered polypeptides having enhanced duration of action
11/20/2013	CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
11/20/2013	CN103402542A Medicinal agent for inhibiting metastasis of malignant tumor
11/20/2013	CN103402537A Use of pegylated recombinant human arginase for treatment of leukemia
11/20/2013	CN103402536A Methods for treating metabolic disorders and obesity with GIP and GLP-1 receptor-active glucagon-based peptides
11/20/2013	CN103402535A Use of ICAM-1 for prevention or treatment of neurological diseases
11/20/2013	CN103402534A Therapeutic method for treating congestive heart failure
11/20/2013	CN103402533A Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom.

1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 3163